2011 ISSVD Terminology and Classification of Vulvar Dermatological Disorders

International Society for the Study of Vulvovaginal Disease, Waxhaw, North Carolina.
Journal of Lower Genital Tract Disease (Impact Factor: 1.99). 05/2012; 16(4):339-44. DOI: 10.1097/LGT.0b013e3182494e8c
Source: PubMed


The study aimed to formulate an easy clinical approach that may be used by clinicians of all backgrounds to diagnose vulvar dermatological disorders.
The International Society for the Study of Vulvovaginal Disease appointed a committee with multinational members from the fields of dermatology, gynecology, and pathology and charged the committee to formulate a clinically based terminology and classification of vulvar dermatological disorders. The committee carried out its work by way of multiple rounds of e-mails extending over almost 2 year's time.
The committee was able to formulate a consensus report containing terminology, classification, and a step-wise approach to clinical diagnosis of vulvar dermatological disorders. This report was presented and approved by the International Society for the Study of Vulvovaginal Disease at the XXI International Congress held in Paris, France, on September 3 to 8, 2011.
The authors believe that the approach to terminology and classification as well as clinical diagnosis contained in this article allows clinicians to make highly accurate diagnoses of vulvar dermatological disorders within the clinical setting. This, in turn, will reduce the need for referrals and will improve the care for women with most vulvar disorders.

191 Reads
    • "First, our sample size was small and explains the use of VD groups to compute basics statistics. Additionally, it is currently very difficult to classify VD [2]. In our study, as most patients attended our VD consultation with a previously confirmed histological diagnosis, our classification system is based on the etiology we thought was most appropriate. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Only a few studies have focused on the description of sexual well-being in patients with vulvar disease (VD). The aim of this study was to test the hypothesis that VD patients have an overall impaired sexual well-being that varies depending on the type of VD. An observational, prospective, single center and 1:1 matched case-control study was conducted in Nantes University Hospital (France). All new patients attending the specific consultation for VD between June 2011 and January 2013 were included. A control group was randomly selected from women who had a scheduled consultation for gynecologic follow-up. A validated French version of the Female Sexual Function Index (FSFI) was used. This self-administered questionnaire was distributed to all case and control women. VD was classified into 4 groups: inflammatory, (pre)malignant, infectious, and other VD. Descriptive statistics and multivariate mixed analyses were performed. Seventy-two VD patients and seventy-two control women completed the FSFI questionnaire. The median FSFI score was 21.1 in the VD patients versus 28.1 in the control patients. In the multivariate analysis, the FSFI score was significantly decreased by an average of 4.5 points (p=0.003) in the VD patients. On the FSFI subscores, VD had significant impacts on items related to "arousal", "pain", "lubrication", "satisfaction", and "desire". When comparing the VD groups, the total FSFI score seemed lower for (pre)malignant VD. This preliminary study showed that VD patients had an impaired sexual well-being. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
    European journal of obstetrics, gynecology, and reproductive biology 08/2015; 194:106-110. DOI:10.1016/j.ejogrb.2015.08.011 · 1.70 Impact Factor
  • Source
    • "At the present time, 2006 ISSVD Classification [1] is still relevant. But, as this classification is of minor help for diagnosis, ISSVD formulated in 2011 a complementary classification as an approach to clinical diagnosis [2]. Clinicians dealing with vulvar complaints should always keep in mind these preliminary considerations and, as a consequence, be convinced that treating vulvar disorders needs a complete anamnestic investigation, examination of the lower genital tract, skin, and sometimes oral mucosae, and dialog between colleagues. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this paper is to present general considerations which should be kept in mind by clinicians in charge of women with vulvar diseases. Four representative vulvar dermatoses are described. Lichen simplex chronicus is a pathological condition related to chemical and mechanical irritant agents. Detrimental effects of these irritants, in the presence of other dermatoses, have to be considered when therapeutic responses are unsatisfactory. Lichen sclerosus is the most common vulvar dermatosis in elderly. However, it should be kept in mind that it may be diagnosed at any age. Lichen planus, in spite of sharing a similar range of etiological factors with lichen sclerosus, is a very distinct entity. Finally, Paget's disease, although rare, is also described especially because of the challenge it represents both clinically and therapeutically.
    01/2014; 2014:595286. DOI:10.1155/2014/595286
  • Source
    • "The diagnosis of vulvar lesions in the postmenopausal state is usually very challenging for the gynecologist. LCH usually presents as erythematous red plaques, eczematous, ulcerative, or polypoid lesions, which can easily lead to a misdiagnosis or interfere with other common vulvar skin lesions of postmenopausal period like lichen sclerosis, lichen planus, vulvar intraepithelial neoplasia, squamous cell carcinoma, candidiasis, psoriasis, contact dermatitis, Paget's disease, herpes simplex or human papilloma virus infections, and melanoma [5]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Langerhans cell histiocytosis (LCH) is a very rare disease of female genital tract, most commonly seen in vulva and unusual in postmenopausal period. Herein, we report the 8th case of pure vulvar LCH in a postmenopausal woman. We pay attention to the differential diagnosis in postmenopausal state, features of pathologic diagnosis, and treatment options.
    09/2013; 2013:962670. DOI:10.1155/2013/962670
Show more